TIL‐rich tumors demonstrated increased CD8+ T‐cells by IHC, while immune‐exclusion tumors displayed a lack of CD8+ T‐cells and frequent expression of PD‐L1 in tumor cells. The gene discussed is CD8A; the disease is neoplasm.